+230.9%
ASTS vs THC
+1,004.2%
-773.3%
-91.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.1% | -1.1% | +8.1% | +7.2% |
| 7D | -21.1% | +3.7% | -24.8% | -21.6% |
| 30D | -46.7% | +9.0% | -55.7% | -47.6% |
| 3M | -52.0% | +10.4% | -62.4% | -53.0% |
| 6M | -54.3% | +45.7% | -99.9% | -58.0% |
| YTD | -55.5% | +42.6% | -98.1% | -59.1% |
| 1Y | -50.5% | +38.8% | -89.2% | -54.2% |
| 3Y | +706.2% | +418.8% | +287.4% | +477.5% |
| 5Y | +165.2% | +275.7% | -110.5% | +95.5% |
| All | +230.9% | +1,004.2% | -773.3% | +146.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling